Czech
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Strana 1 z 63 Výsledek
Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to inhibiting amyloid deposit formation and dissolving pre-formed amyloid deposits and to methods and pharmaceutical compositions for treating brain inflammation and for treating inflammation associated with amyloid or
Method and filamentous phage for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to inhibiting amyloid deposit formation and dissolving pre-formed amyloid deposits and to methods and pharmaceutical compositions for treating brain inflammation and for treating inflammation associated with amyloid or
Use of isolated bacterial amyloids for treatment of inflammatory disorders or diseases of the epithelium
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The invention relates to the use of isolated bacterial amyloids or the use of recombinant bacteria for the treatment of inflammatory disorders of the epithelium.
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via
Materials and methods related to the inflammatory effects of secreted amyloid precursor proteins
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Unchecked inflammation in the brain results in neural tissue necrosis which can manifest as seizures, dementia, loss of mental capacities, or death. For example, epilepsy, dementia due to Alzheimer's disease, stroke and traumatic brain injury have all been linked to
HUCBC treatment of amyloid-associated disease
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF INVENTION
This invention relates to amyloid protein-based diseases. Specifically, the invention relates to mediators of amyloid peptide levels, immune responses, and treatments of Alzheimer's disease.
BACKGROUND OF THE INVENTION
Amyloid diseases, such as Alzheimer's disease, Huntington's
HUCBC treatment of amyloid associated disease
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF INVENTION
This invention relates to amyloid protein-based diseases. Specifically, the invention relates to mediators of amyloid peptide levels, immune responses, and treatments of Alzheimer's disease.
BACKGROUND OF THE INVENTION
Amyloid diseases, such as Alzheimer's disease, Huntington's
Use of pyridinyl-pyrimidinylamino-benzamide derivatives for the treatment of amyloid related disorders
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The invention relates to the use of compounds (hereinafter: "COMPOUND") or a N-Oxide or a pharmaceutically acceptable salt thereof having an activity on protein kinases VEGFR-2, Tie-2, c-Src, c-Met, FGFR-1, Flt-1, HER-2, c-Abl, c-Raf, PDGFR-beta, c-Kit, or on a combination of the above enzymes, for
Amyloid beta peptides as therapy for multiple sclerosis
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
Multiple Sclerosis (MS) is an autoimmune disease of the CNS of unknown etiology that affects .about.400 000 Americans. In MS, myelin reactive T cells enter into the brain and spinal cord and mediate destruction of the myelin sheath surrounding neurons resulting in
Assay and purification of amyloid components, applications, and kits therefor
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
The invention relates to a new method of immunological analysis for serum amyloid A protein (SAA) and serum amyloid P-component (SAP), kits therefor and a method of purification of SAA and SAP.
BACKGROUND OF THE INVENTION
Following most forms of tissue injury, infection or inflammation, the
Inhibiting amyloid-beta peptide/rage interaction at the blood-brain barrier
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
BACKGROUND OF THE INVENTION
The invention relates to inhibiting specific receptor-ligand interaction between Alzheimer's amyloid-.beta. peptide (A.beta.) and the Receptor for Advanced Glycation Endproducts (RAGE).
A number of genetic, cellular, biochemical, and animal studies suggest accumulation of
Diagnostic assays of secreted biological fluids for detection of infection and inflammatory conditions
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present invention relates generally to the field of diagnostics. In particular, the invention provides a method for diagnosing infection and other inflammatory conditions by measuring the presence of Serum Amyloid A in a secreted biological fluid. The invention further
Biomarkers for inflammation of the liver
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
RELATED APPLICATIONS
This application is a national stage application (under 35 U.S.C. .sctn.371) of PCT/DE2007/001427, filed Aug. 10, 2007, which claims benefit of German application 102006037613.7, filed Aug. 10, 2006 and German application 102006048249.2, filed Oct. 12, 2006.
DESCRIPTION
The
Model for chronic cerebral inflammation by intracerebral injection of double stranded RNA
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The present invention relates to an animal model for use in the study of human diseases, conditions and disorders, especially neurodegenerative diseases, that are characterized by the damage or dysfunction of the central nervous system. The present invention also relates to
Cromolyn compositions and methods thereof
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The invention relates generally to cromolyn compositions and methods thereof. Specifically, the invention relates to effectively delivering cromolyn particles to a patient in need thereof for treating various diseases.
BACKGROUND OF THE INVENTION
Cromolyn (also known as
Methods for delivering cromolyn
Články mohou překládat pouze registrovaní uživatelé
Přihlášení Registrace
FIELD OF THE INVENTION
The invention relates generally to methods of delivering cromolyn to a patient in need thereof, to methods of treating amyloid-associated conditions and inflammatory or allergic lung diseases, and to blister packs and kits comprising cromolyn.
BACKGROUND
Cromolyn (also known
Nejúplnější databáze léčivých bylin podložená vědou
- Funguje v 55 jazycích
- Bylinné léky podporované vědou
- Rozpoznávání bylin podle obrázku
- Interaktivní mapa GPS - označte byliny na místě (již brzy)
- Přečtěte si vědecké publikace související s vaším hledáním
- Hledejte léčivé byliny podle jejich účinků
- Uspořádejte své zájmy a držte krok s novinkami, klinickými testy a patenty
Zadejte symptom nebo chorobu a přečtěte si o bylinách, které by vám mohly pomoci, napište bylinu a podívejte se na nemoci a příznaky, proti kterým se používá.
* Všechny informace vycházejí z publikovaného vědeckého výzkumu
